Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vivos Therapeutics Inc.

    NASDAQ: VVOS · Real-Time Price · USD
    2.85
    0.37 (14.92%)
    At close: Jun 20, 2025, 3:59 PM
    3.05
    7.02%
    Pre-market: Jun 23, 2025, 07:06 AM EDT
    14.92%
    Bid 2.52
    Market Cap 16.79M
    Revenue (ttm) 14.63M
    Net Income (ttm) -11.24M
    EPS (ttm) -1.04
    PE Ratio (ttm) -2.74
    Forward PE -2.67
    Analyst Buy
    Ask 3.12
    Volume 498,302
    Avg. Volume (20D) 108,824
    Open 2.70
    Previous Close 2.48
    Day's Range 2.56 - 2.90
    52-Week Range 1.97 - 6.28
    Beta 6.99

    About VVOS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol VVOS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for VVOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    1 month ago
    -16.99%
    Vivos Therapeutics shares are trading lower after ... Unlock content with Pro Subscription
    3 months ago
    +10.9%
    Vivos Therapeutics shares are trading higher after the company announced the expansion of its alliance model to two more Colorado locations.
    news image

    1 month ago · seekingalpha.com

    Vivos Therapeutics, Inc. (VVOS) Q1 2025 Earnings Call Transcript

    Vivos Therapeutics, Inc. (NASDAQ:VVOS ) Q1 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Brad Amman - CFO Kirk Huntsman - Chairman and CEO Conference Call Participants Do ...

    news image

    1 month ago · zacks.com

    Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates

    Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $1.63 per share a year ago.

    news image

    1 month ago · zacks.com

    Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

    Vivos Therapeutics (VVOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · seekingalpha.com

    Vivos Therapeutics, Inc. (VVOS) Q4 2024 Earnings Call Transcript

    Vivos Therapeutics, Inc. (NASDAQ:VVOS ) Q4 2024 Earnings Conference Call March 31, 2025 5:00 PM ET Company Participants Bradford Amman - CFO, Treasurer & Secretary Kirk Huntsman - Co-Founder, Chairman...

    news image

    2 months ago · zacks.com

    Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates

    Vivos Therapeutics, Inc. (VVOS) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $3.05 per share a year ago.

    Add to Watchlist